VectivBio, a global, clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, announced the appointments of Sarah Holland, Ph.D., as Chief Business Officer and Aditya Venugopal, Ph.D., as Vice President of Business Development. Dr. Holland will be based in Switzerland and Dr. Venugopal will be based in the U.S., further expanding the…